Variant report
Variant | esv3425575 |
---|---|
Chromosome Location | chr10:27600446-27602444 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:4)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:4 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr10:27600676-27600841 | K562 | blood: | n/a | n/a |
2 | CEBPB | chr10:27601912-27602036 | HepG2 | liver: | n/a | chr10:27601959-27601970 |
3 | CEBPB | chr10:27601941-27601990 | K562 | blood: | n/a | chr10:27601959-27601970 |
4 | MYC | chr10:27600969-27601008 | GM12878 | blood: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
RNU6-666P | TF binding region |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs564654494 | chr10:27600646-27600647 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs578085184 | chr10:27600649-27600650 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs543917160 | chr10:27600659-27600660 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs563584453 | chr10:27600669-27600670 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs559585016 | chr10:27600744-27600745 | Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs372740726 | chr10:27600777-27600778 | Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs528496570 | chr10:27600788-27600789 | Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs548954467 | chr10:27600797-27600798 | Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs548176382 | chr10:27600850-27600851 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs191428622 | chr10:27600876-27600877 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs144353671 | chr10:27600897-27600898 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
12 | rs374673044 | chr10:27600908-27600909 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs568256121 | chr10:27600924-27600925 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs77672877 | chr10:27600937-27600938 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs61849720 | chr10:27600954-27600955 | Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs183564342 | chr10:27600961-27600962 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs546685080 | chr10:27601617-27601618 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs566495931 | chr10:27601620-27601621 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs12247140 | chr10:27601629-27601630 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs191077424 | chr10:27601683-27601684 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs138993705 | chr10:27601695-27601696 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs11015691 | chr10:27601717-27601718 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
23 | rs534644088 | chr10:27601723-27601724 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs373164478 | chr10:27601735-27601736 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs182209237 | chr10:27601745-27601746 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs542725405 | chr10:27601763-27601764 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs114304284 | chr10:27601857-27601858 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs186856478 | chr10:27601870-27601871 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs544994324 | chr10:27601880-27601881 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs191707197 | chr10:27601949-27601950 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs530694956 | chr10:27601953-27601954 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs112092534 | chr10:27601976-27601977 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs200353527 | chr10:27601999-27602000 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs34400888 | chr10:27602000-27602001 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs201033919 | chr10:27602009-27602010 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Melanoma | 18172304 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Lung cancer | 18438408 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Oral cancer | 21386901 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Behavioral abnormalities | 21522184 | CNVD |
Dysmorphic features | 21522184 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Autism | 21439084 | CNVD |
Maculopathy | 20981449 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Breast cancer | 21364760 | CNVD |
abnormal development | 18461090 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Glioblastoma multiforme | 21525872 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:27600600-27601000 | Active TSS | Placenta | Placenta |
2 | chr10:27601600-27602000 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
3 | chr10:27601800-27602000 | Enhancers | Primary neutrophils fromperipheralblood | blood |